Is it true that chemotherapy can damage my heart?

 

Q: Is it true that chemotherapy can damage my heart? 

A: Some chemotherapy drugs may damage heart muscles. This can lead to problems that may appear shortly after treatment or years later. Some damage is mild and detectable only through testing; other may be severe, resulting in conditions such as congestive heart failure. Limiting the cumulative dose of heart-damaging drugs helps prevent cardiac problems, as does giving smaller doses more frequently or taking an additional drug specially formulated to reduce damage.

Talk with your doctor about any possible cardiac effects from the medication you are being given. If you are to receive a chemotherapy drug that has the possibility of weakening the heart muscle, a baseline measurement of your heart function will be ordered through an echocardiogram or MUGA scan. These are noninvasive tests that can be performed at your hospital outpatient department or in a cardiologist's office.
--Bernice Crook, RN, OCN

Learn more about cardiac problems and other long-term side effects from treatment.

Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health